News

Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its ...
The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...
Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The ...
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...
Quarterly Net Profit at Rs. 1.34 crore in June 2025 up 950.06% from Rs. 0.16 crore in June 2024. EBITDA stands at Rs. 1.34 ...
Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock ...
Modernization of “manufacturing technologies and controls through further advanced automation and artificial intelligence” ...
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...